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Efficacy of platelet rich plasma in third molar impaction surgery 
 
Abstract : The use of autologous platelet concentrates mainly platelet rich plasma has been of 
relevance recently in the field of Oral and Maxillofacial surgery. These concentrates had the 
ability to improve the hard and soft tissue healing.This ability of the platelet concentrates had 
been studied in the healing after mandibular third molar impaction surgery. The various 
parameters like bone density,soft tissue healing, post operative pain,swelling and alveolar osteitis 
were taken into account. The patients were evaluated on day 1,day 2,day 3,day 7, first month and 
second month post operatively. The values for each parameters were found out and tabulated.  
Materials and methods:12 patients , 7 males and 5 females with bilaterally impacted 
mandibular third molars were included in the study. Autologous platelets were concentrated.This 
was applied on one of the sockets which was randomly taken as the test side. The other socket 
was treated as the control. 
Results: Statistical analysis was done using Mann Whitney U test for pain and soft tissue 
healing, which revealed the values for pain being statistically significant for the test side and no 
statistical difference was noted for soft tissue healing. Bone density and swelling were analysed 
with T-test . Bone density values were statistically significant for the test side, while swelling did 
not show much statistical significance. None of the patients presented with alveolar osteitis in 
any side. 
Summary and conclusion: platelet rich plasma is a surgical additive that can be used to 
improve bone and soft tissue healing. It contains a wide array of growth factors that are 
responsible for their healing potential. 
Keywords: platelet concentrates, growth factors, bone density, gray value scale, alveolar 
osteitis,soft tissue healing, pain,swelling. 
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Introduction  
One of the greatest challenges in clinical research is the development of surgical  
additives that can increase the healing potential . The healing of hard and soft  
tissues is mediated by a wide range of intracellular and extracellular events that are  
regulated by signalling proteins. Platelets play an important role not only in  
hemostasis, but also in wound healing. 
 
A lot of surgical additives have been introduced into the field of Oral and  
Maxillofacial Surgery with the aim of better soft and hard tissue healing, pain  
control, reduction of dry socket and control of swelling.  
 
 Platelet concentrates are blood derived products used for the prevention of  
haemorrhages due to serious thrombocytopenia of central origin. Oral surgery in  
cardiac  patients under anticoagulant therapy may be facilitated with platelet  
concentrates
1,2
.  
 
The development of  platelet concentrates as bioactive surgical  
additives that are applied locally to promote wound healing stems from use of   
fibrin adhesives. The evolution of platelet concentrates, thus  dates back to 1970  
when fibrin glue was introduced. This was prepared by polymerizing fibrinogen  
with calcium and thrombin. This product was available in blood bank and this  
carried   a risk of  disease transmission, like hepatitis and HIV 
3
. So the fibrin  
adhesives were banned in the  United States as early as 1977.  After this ,studies  
were concentrated on the preparation of autologous platelet concentrates . 
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Platelet Rich Plasma was first used in cardiac surgery by Ferrari  in 1987 as an  
 
autologous transfusion component after an open heart operation to avoid  
 
homologous blood product transfusion
4
. PRP has also been utilized to treat intra- 
 
articular injuries. Examples include arthritis, arthrofibrosis, articular cartilage  
 
defects, meniscal injury, and chronic synovitis or joint inflammation
5
. The  
 
use of platelet rich plasma in sports medicines were elaborated by various authors. 
 
This was introduced into the field of Oral and Maxillofacial Surgery  in 1998 ,  
 
Marx being the pioneer. 
 
 
Thus the first generation platelet concentrates otherwise called as Platelet Rich  
 
Plasma was introduced. The various uses of platelet rich plasma in Oral and  
 
maxillofacial surgery includes sinus lift procedures, ridge augmentations, socket  
 
preservation, alveolar cleft and palate repair , alveolar bone grafting, oral or nasal  
 
fistula closure , intrabony defects , jaw reconstruction , mandibular fractures 
6
, and  
 
soft tissue gingival procedures. 
 
 
Third molars, the last teeth to erupt into the human  dental arch, have been shown  
 
to be the most frequently impacted  teeth in all human ethnicities. The main factors  
 
contributing to impaction are an inadequate dental arch space and erratic   eruption  
 
paths. The impaction surgery done for the removal of  the third molars presents  
 
itself with a variety of factors which are uncomfortable to the patient. Pain, 
 
 swelling, trismus, infection, bone loss, pocket formation distal to the second molar  
 
being a few factors . 
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Immediately following tooth removal, a healing process begins that affects the 
 
eventual alveolar bone volume and architecture of the alveolar ridge. Satisfactory  
 
and timely healing are essential to obtain ideal functional reconstruction. 
 
Traumatic removal of a tooth, or a poor healing response, may lead to excessive 
 
bone loss . Patients and clinicians could benefit if a cost-effective, simple  
 
technique  were available that decreased bone-healing time and increased the  
 
predictability of favorable results. The objective of this study was to determine  
 
whether the application of platelet rich plasma (PRP) to a tooth extraction site  
 
would facilitate bone healing. 
 
 
 Following extraction of a tooth, a blood  clot forms in the  socket and the healing  
 
process begins. The  early healing events include the formation of  
 
granulation tissue  within the socket, which is progressively replaced  with newly   
 
formed bone.  
 
 
The healing process is considered complete after 4–6 months, once bone   
 
remodelling takes place. In order to reduce alveolar  bone dimensional changes,  
 
several techniques aiming at  enhancing the regeneration process in the extraction  
 
socket , better soft tissue healing, reduction in post operative pain and swelling  
 
were introduced .Recently, the use of platelet concentrates has been proposed as an  
 
aid for enhancing regeneration of osseous  and epithelial tissues in oral surgery.  
 
 
 
Several in vitro studies, animal experiments and clinical trials suggested that  
 
platelet  concentrates may effectively trigger stimulation of osseous and   
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soft tissue regeneration, and reduce inflammation, pain and  unwanted side effects. 
 
Platelets are known to perform multiple functions during injury and tissue repair. 
 
 Platelets initiate the body’s response to a  normal sequence of events that provide  
 
clotting and healing of  the damaged tissue. 
 
 
 
 There are 4 phases of wound healing: the hemostatic phase (clot  formation), the  
 
inflammatory phase ( clean-up and  recruitment),the proliferative phase   
 
(regeneration), and the tissue  remodeling phase. Although these phases appear  
 
independent  from one another, they overlap significantly during the healing  
 
process. Naturally occurring materials present in the body provide the signals and  
 
structures for repair, regeneration, and  healing. These may be considered as  
 
“autologous biomaterials”  distinguishing them from recombinant or synthetic  
 
“biomaterials.” 
 
 
Postsurgically, blood clots initiate the healing and regeneration of hard and soft  
 
tissues. Using platelet-rich plasma, is a method to accelerate and enhance the body’s  
 
natural wound-healing mechanisms. Platelets primarily are involved in wound  
 
healing through clot formation and the release of growth factors that initiate and  
 
support  wound healing. 
 
 
 Increasing the concentration of autologous  biomaterials to a wound site enhances  
 
healing. Two important  autologous biomaterials, platelets and fibrin, play a central 
 
 role  in the formation of the clot. A number of derived growth factors  are released  
 
from the  platelets. They are critical for any wound to heal and are  involved in  
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every phase of wound healing. They are contained in  the α granules of  platelets as 
 
 well as other cells such as  macrophages and endothelium. Platelet growth factors   
 
are responsible for  the  early migration of cells to the injury site and the triggering   
 
of mitosis of these cells . 
 
 
After tissue injury, platelets become exposed to damaged blood vessels, which  
 
places them in direct contact with collagen, the basement membranes 
 
of  capillaries, and sub endothelial microfibrils. This interaction causes the platelets 
 
to aggregate at the site and change from a rounded shape to one that includes large, 
 
 sticky protuberances, or pseudopodia. This process is called activation. During  
 
activation, the  alpha granules fuse with the platelet plasma membrane and 
 
release their protein contents to the surroundings. 
 
 
 
Specific platelet-isolated growth factors include platelet-derived  growth factor  
 
(PDGF), transforming growth factors-beta (TGF- β),vascular endothelial growth  
 
factor (VEGF), and epithelial growth factor (EGF)
7
. Growth factors released  
 
from platelets and  contained within the clot send out signals to trigger cell  
 
division. The growth factors initiate connective tissue healing, bone regeneration  
 
and repair, increase mitogenesis of fibroblasts, stimulates angiogenesis in the  
 
wound bed and activates macrophages. The newly created blood vessels and blood  
 
flow brings necessary nutrients and oxygen for optimal healing. The growth factors  
 
act on stem cells , osteoblast  precursors and fibroblasts. 
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Platelet-rich plasma (PRP) is a new biomaterial that consists of a high  
 
concentration of human autologous platelets in a small amount of plasma .Platelet- 
 
rich plasma can be defined such  that ,it is a volume of autologous  plasma   
 
that has a platelet concentration above  baseline.  
 
 
 Because the  scientific proof of bone and soft tissue healing  enhancement  has  
 
been shown using PRP with 1,000,000  platelets/μL, it is this  concentration of  
 
platelets in a 5-ml  volume of plasma which is  the working definition of PRP  
 
 today
8
. Lesser concentrations cannot be relied upon to enhance wound healing,  
 
and greater concentrations have not yet been  shown to further enhance wound  
 
healing . 
 
 
Because PRP is developed from autologous blood, it is  inherently safe and is free  
 
from transmissible diseases such as  HIV and hepatitis. Within PRP, the increased  
 
number of  platelets delivers an increased number of growth factors to the surgical  
 
area.  
 
 
Thus PRP is the combination of seven native growth factors  within a normal clot  
 
as the  carrier. The clot is composed of fibrin, fibronectin, and vitronectin, which  
 
are cell adhesion molecules required for cell migration such as is seen in  
 
osteoconduction, wound epithelialization, and osseointegration. 
 
 
 Platelets are attracted to a wound or injury site stimulating the clotting and healing  
 
cascades.  Growth factors signal undifferentiated stem cells to the site, promote 
 
 cell mitosis, and stimulate osteogenesis and angiogenesis. Cytokines,which attract neutrophils,  
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are also released from platelet granules. Concentrating platelets 4-5 times the baseline level  
 
accelerates the healing process. When platelet rich plasma is mixed with an activator, a platelet  
 
gel will form. Clinical applications of platelet gel are numerous. Some benefits include 
 
 a marked decrease in post-surgical swelling,reduction in surgical site pain, and acceleration 
 
 of bone growth and soft tissue healing.  
 
 
The clinical implications of the plasma gel are many in the field of reconstructive surgery. In  
 
neurosurgery it is used as a biologic sealant to aid in watertight dural closure.In facial and  
 
reconstructive plastic surgery the gel is used as a hemostatic agent in the surgical bed. During  
 
radical neck dissections this is used as a hemostatic agent as well as a lymphatic sealant. This gel  
 
has also been found to be important in treating chronic wounds and burns. 
 
 
The current study deals with the efficacy of autologous platelet concentrates in third molar  
 
impaction surgery. The hard and soft tissue healing initiated by the platelet concentrates are  
 
analysed. 
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AIM  
 
Comparison of the efficiency of platelet rich plasma ( PRP ) in third molar  
impaction surgery in patients with bilaterally impacted mandibular third molars  
where one side was treated as test  ( PRP side ) and the other side treated as  
control ( non PRP ) side. 
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OBJECTIVES  
 
To reduce the post operative complications like pain, swelling,dry socket,  
improvement of soft tissue healing and bone density with the use of platelet rich  
plasma on the basis of a comparitive study on the same patient with bilaterally  
impacted third molars. 
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Review of literature 
Sidney Shaw
9
 ( 1970 ) did the estimation of platelet adhesiveness on whole blood and  platelet 
rich plasma. Compared the variation in platelet adhesiveness using whole blood and citrated 
plasma. 
 
Robert E Marx
7
 ( 1998 ) stated that platelet rich plasma contains a concentration of platelets 
and growth  factors . The study evidenced that the growth factor additions to bone grafts 
produced a quantifiably enhanced result in comparison with grafts performed without its use. 
The fact that PRP is an autologous preparation eliminates concerns about disease transmission 
and immunogenic reactions. 
 
Regina Landesberg
10
 ( 1998 ) evaluated the risks of using platelet rich plasma. And she has 
given the various other thrombin preparations like recombinant human thrombin and autologous 
thrombin to replace the bovine thrombin 
 
Regina Landesberg et al
11
 (2000 ) emphasized on quantification of growth factor levels using a 
simplified method of platelet rich plasma gel preparation. The study compared two methods of 
preparing platelet rich plasma and the levels of PDGF and TGF beta in each preparation. Use of 
gel preparation is equivalent to using calcium chloride and bovine thrombin. The levels of DPGF 
and TGF β were same regardless of which method was used for clot formation. 
 
Dugrillon 
12
 ( 2001 ) showed the effects of autologous concentrated platelet rich plasma for local 
application in bone regeneration. The study shows a blood bank procedure  to generate PRP with 
defined quality control. A comparison was evaluated between the concentrated PRP   ( c PRP ) 
and PRP. The concentrated PRP showed a 12- 17 times increase in the growth factor content. 
REVIEW OF LITERATURE 
 
11 | P a g e  
 
Su-Gwan Kim et al 
13
 ( 2002 )compares study of osseointegration of avana implants in a   
demineralized freeze dried bone alone or with platelet rich plasma. The results  showed that bone 
defects around titanium implants can be treated successfully with demineralized freeze dried  
bone powder and that PRP increases bone formation. The study showed that the  freeze dried 
bone used as a mixture with PRP increased the osseointegration. 
 
 Tara L Aghaloo
14
  ( 2002 ) did  a pilot study in rabbit cranial defects with platelet rich  plasma. 
The study showed that no significant difference in bone formation was seen when PRP was used 
alone . There  was a significant increase in bone formation and bone density when the PRP was 
used along with bone. 
 
Gernot Weibrich
15
 ( 2002 )  compared the growth factor levels in platelet rich plasma in relation 
to age , sex and platelet count. PRP contains many growth factors. Three  of those PDGF αβ, 
TGF β 1, and IGF 1 were found in high concentrations and PDGF ββ and TGF β 2 were found in 
low quantities. Major age and gender specific differences were not noted. 
 
 Arlene Rodriguez
16
  ( 2003 ) indicated the use of platelet rich plasma with   deproteinated  
bovine  bone in maxillary sinus augmentation. The article concluded that the combination  of 
these two materials is effective in maxillary sinus augmentation in  severely resorbed posterior 
maxillae. They produced new bone with higher density. The endothelial cells, adipocytes and  
fibroblasts maybe transformed into osteoblasts on a variety of biochemical signals via cytokines 
provided in the PRP. 
 
Sanchez et al
17
 ( 2003 ) in their review has elaborated certain potential risks of using PRP. This 
was with the use of bovine thrombin,which may lead to development of antibodies to factor V , 
leading to life threatening coagulopathies.Bovine thrombin is known to contain factor V  which 
could stimulate the immune system. 
 
REVIEW OF LITERATURE 
 
12 | P a g e  
 
Hiroshi Kitoh et al 
18
( 2004 )  showed the clinical results of distraction osteogenesis with 
transplantation of marrow derived mesenchymal cells and platelet rich plasma were reviewed. 
PRP contained several growth factors , coagulate immediately by a minute introduction of 
thrombin or calcium. They concluded that PRP reduce the treatment period by acceleration of 
bone regeneration during distraction osteogenesis. 
 
 M.A.W Merks et al 
19
 ( 2004) in his  article mentions the reconstruction of the mandible  with 
preshaped 2.3 mm titanium plates , autogenous particulate cortico cancellous bone grafts and 
platelet rich plasma. Describes all the growth factors  present in PRP, which have positive effects 
on vascular ingrowth and bone healing. Because of this PRP in combination with non 
vascularised bone grafts is advantageous in skeletal reconstruction. Since the reconstruction was 
mainly done after ablative surgery the article also proves that there are no factors in PRP that 
causes new tumour formation. 
 
J. Camilo Roldan et al 
20
 ( 2003 )did a comparative study on bone formation in the presence of 
platelet rich  plasma and bone morphogenic protein 7. This article explains the preparation of 
PRP. Showed that the TGF β present in the PRP has the osteoinductive property. 
 
Tomoki  Oyama et al 
21
 ( 2004 )showed the efficacy of platelet rich plasma in alveolar bone 
grafting. They found that PRP was a safe and cost effective source for growth factors and was 
easy to extract. It could enhance the osteogenesis of alveolar bone grafting in cleft lip and palate 
patients. Here platelet rich plasma was added to the particles of cancellous bone .Human fibrin 
glue was added to consolidate the bone chips and PRP. It was revealed that PRP could  enhance 
osteogenesis in a remodeling phase within the first 4 months.  
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Candan  Efeoglu   et al 
22
 ( 2004  ) showed the preparation of low cost autogenous platelet rich 
plasma for use in minor bone grafting procedures. Their methods proved that PRP could be 
prepared within 30 minutes. Platelet counts in PRP were increased with respect to venous 
platelet counts. Most of the studies on PRP  preparation was focused on machines used in its 
preparation, presence of growth  factors and the anticoagulants used. EDTA was the preferred 
anticoagulant used. Studies using flow cytometric techniques and automated blood analyzers 
reveal that various anticoagulants including citrates activate platelets but the activation  done by 
EDTA and heparin are much stronger.  
 
 Robert E Marx
23
 ( 2004 ) showed in this article the evidence to support the use of PRP in 
maxillofacial surgery. Shows how PRP works , the amount of platelets enough, what all clinical 
conditions that benefit from PRP, the safety of PRP, and whether it promotes infection. Today 
PRP remains the sole growth factor available to maxillofacial surgeons. PRP works via 
degranulation of alpha granules in platelets. A  PRP count of  1 million/µL as measured in the 
standard 6 mL aliquot is the benchmark for therapeutic PRP. PRP enhances osteoprogenitor cells 
in the host bone and in bone grafts. Shows the use of PRP in continuity defects, sinus lift 
augmentations , horizontal and vertical ridge augmentations and periodontal and peri implant 
defects. Since it is an autogebous preparation, it is safe to use.PRP has a pH of 6.5 – 6.7. No 
evidence to show it promotes infection. 
 
Earl G Freymiller et al
24
 ( 2004 ) Showed the use of platelet rich plasma with autogenous 
bone,with anorganic bone material, with organic bone matrix and when used alone. When PRP 
was used alone in extraction sockets, improved epithelialization and bone density was noted. 
There is a lower rate of alveolar osteitis, less pain and  more dense radiographic bone healing. 
Explains the growth factors present in PRP and how they are released ( degranulation ). 
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JJ Thorn et al 
25
( 2004 )Compared the autologous fibrin glue with the platelet rich plasma. Also 
showed how the fibrin glue can be used as the transplant material for PRP. The platelet gel is a 
modification of the fibrin adhesive. The gel contains a high concentration of platelets, nearly 
300-400% of blood. The concentration of fibrinogen was 12 times less in PRP. Also the PDGF  
also was higher in fibrin glue. The clinical application of fibrin glue also appeared to be easier 
than PRP. 
 
BH Choi et al 
26
(2004 )  Evaluated the effect of platelet rich plasma on bone regeneration in an 
autogenous bone graft. Variations  in the concentration of platelet derived growth factors are 
known to influence bone healing. Platelets and growth factors are known to likely act more 
during the early stage of bone graft healing. 
 
Gilberto sammartino et al 
27
 ( 2005 )Showed that PRP is effective in inducing and accelerating 
bone regeneration for the treatment of periodontal defects at the distal root of mandibular second 
molarafter surgical extraction of a deeply impacted third molar. There is a notable reduction in 
probing depth and an improvement in the probing attachment level in those cases treated with 
PRP. The mechanism by which PRP can influence the periodontal regeneration was due to the 
presence of PDGF and TGF -β. Due to the presence of the fibrin clot the PRP gel permits 
stabilized coagulation of blood , thereby  favouring regeneration of the osseous defect, mostly in 
the early stages. TGF -β  could favour the differentiation of osteoblasts and cementoblasts and 
the production of fibronectin. 
 
Regina Landesberg et al 
28
( 2005 ) Showed the activation of platelet rich plasma using 
thrombin receptor activator peptide. Gives an alternate preparation of PRP. Shows the use of 
TRAP to activate  clot formation in the preparation of PRP. This is used as an alternative to 
bovine  thrombin. Bovine thrombin is associated with the formation of antibodies to factor V and 
XI and thrombin that may result in coagulopathies. TRAP minimizes  the amount of clot 
retraction. 
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Rick C Tsay et al
29
 ( 2005 ) PRP preparation with thrombin results in a large immediate release 
of growth factors that could be lost into the interstitium in vivo. Thrombin Receptor Activator 
Peptide -6 ( TRAP ) proves more effective than thrombin in sustaining growth factor levels 
critical for the cascade of events leading to bone formation. Growth factor retention was a 
function of both the substrate used and the specific growth was examined. 
 
BH Choi et al ( 2005 )
30
 The result of their study showed that the viability and proliferation of 
alveolar bone cells were suppressed by high PRP concentrations while they were stimulated by 
low concentration of PRP 0.5 -5 % PRP stimulates osteoblastic proliferation. A dilution of PRP 
concentrations to a level suitable for cell proliferation may be necessary for use in bone grafts in 
order to enhance bone  cell growth within PRP treated bone graft 
 
GRJ Swennen et al 
31
( 2005 )Showed the effect of platelet rich plasma in the cranial distraction 
osteogenesis in an animal model.  All the growth factors in PRP were given. The preliminary 
result of the study showed that PRP only had an effect on bone regeneration if active distraction 
was started immediately after application of PRP in the distraction gap. 
 
Yoichiro Ogino et al
32
 ( 2006 )Showed the contribution of platelet derived growth factors 
transforming growth factor beta 1, and insulin growth factor in platelet rich plasma to the 
proliferation of osteoblast like cells.PRP could stimulate the mitogenic activity of osteoblast 
cells. The amount of growth factors present in PRP were measured by ELISA. PDGF was the 
most dominant factor that could stimulate the proliferation of osteoblast like cells. 
 
Barry L Eppley et al
33
 ( 2006 )Gives the technical concepts and evaluation of platelet rich fibrin 
a second generation platelet concentrate. Compares the biomechanical properties of fibrin 
adhesives, concentrated PRP and platelet rich fibrin. Emphasis is given more on the technical 
aspects in the production of PRP and PRF. Describes the earlier use of PRP in thrombopenias. 
Also describes the functions of platelets, haemostatic mechanisms and clotting cascades. 
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PA Everts et al 
34
( 2006 ) healing of hard and soft tissue is mediated by a complex array of 
intracellular and extracellular events regulated by signaling proteins.   Detailed emphasis of all 
the various growth factors present in platelet rich plasma is given. 
 
MZ Casati et al
35
 ( 2006 )Studied the efficacy of platelet rich plasma in bone regeneration 
around the peri implant bone defects. It was found that platelet rich plasma did not improve bone 
regeneration around peri implant defects in dogs 
 
Faleh M Tamimi et al
36
 ( 2007 )Did a comparative study of 2 methods for obtaining platelet 
rich plasma. Double and single centrifugation are the most commonly used technique . Double 
centrifugation method yielded 336% while the single centrifugation yielded 227 %. The PRP 
obtained is calcium activated before being applied over the surgical site. Platelet concentration 
was calculated using the given equation in the article. Both these methods were easy to use , can 
concentrate platelets without damaging them  despite the centrigugation process the platelets 
suffer. The studies used immunohistochemistry to analyse the growth factors present in PRP. 
 
Mozzati M et al
37
 ( 2007 )Studied on the clinical application of PRP in the extraction of  
impacted mandibular third molar. A control side and a PRP side were selected. Various 
parameters were set including probing depth in relation to adjacent molar, pain, swelling and 
bone density measured by digital OPG. Soft tissue healing criteria was also set. Digital OPG was 
taken at the end of first week, second week and one month post operatively. The results of the 
study showed a remarkable improvement in bone healing and regeneration, pain control and soft 
tissue healing. The edema did not have any change.  The study also showed that the side where 
PRP was applied had a remarkable soft tissue healing. This was evaluated in the first 2 weeks. 
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Helen H Lu et al 
38
( 2007 ) Studied on the controlled delivery of platelet rich plasma derived 
growth factors for bone formation. The bioactivity of released factors were maintained in vitro 
and they promoted cell proliferation and alkaline phosphatase activity.  Described an alginate 
based delivery system for regulating the release of PRP derived growth factors. 
 
James L Rutkowski et al
39
 ( 2007 )  Showed in his retrospective study about the benefits of 
PRP in prevention of alveolar osteitis.  The  results showed that the alveolar osteitis occurring 
following tooth extraction was 2.81 times greater in patients not receiving PRP. The growth 
factors present in PRP are responsible for this. Mesenchymal stem cells differentiate into 
osteoblasts when stimulated by the growth factors. 
 
RECM Mooren et al 
40
 ( 2007 )Animal study was conducted in goats in similar sized cranial 
defects which were    created. This study found that PRP did not have an effect in either the early 
or late bone healing. 
 
Jan Slapnicka et al 
41
( 2008 )   Study purpose was to evaluate the effect of progressively 
increasing  concentrations of activated and non activated platelet rich plasma on proliferation of  
human osteoblasts. Activated PRP resulted in higher proliferation of osteoblasts compared with 
non activated PRP  ( 0.38 times to 0.95 times ). Here autologous human thrombin was used for 
platelet activation. 
 
XL Griffin et al 
42
(2008 )   Studied the clinical use of platelet rich plasma in the promotion of 
bone healing.  Augmentation of PRP with autologous bone graft alone is not as effective as in  
combination with bone marrow or stromal cells.  Concentration of platelets determine the 
efficacy. The lack of consistency in platelet concentration makes comparative studies less 
reliable. 
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Bahadir Gurbuzer et al 
43
 (2008 ) Healing process with PRP after the use in impacted third 
molar extraction sockets were evaluated. Scintigraphic study was conducted. The activity  was 
noted in post operative weeks 1 and 4. Bone regeneration process starts with release of PDGF 
and TGF beta. Since the lifespan of the platelets are less than 7 days , the growth factors present 
in PRP  exerts their effect in early stages of wound healing ( post operative weeks 1 and 2 ). PRP 
in conjunction with other graft  material yielded better results. 
 
Elisabeth Semple et al  
44
( 2008 )   Comparison was done between the patients own thrombin 
and bovine thrombin as an activator for platelets. Thrombin from the patient had a lower  growth 
factor content than the bovine thrombin. The amount of growth factor  released depends on the 
rate of activation and the number of platelets.  
 
HC Kroese –Deutman et al 45 ( 2008 ) The effect of platelet rich plasma was evaluated in a 
rabbit segmental bone defect. Histomorphical studies revealed that bone formation was higher in 
implants with PRP.  It was concluded that PRP had a stimulatory effect on bone formation in 
titanium fiber mesh filled with autologous bone graft in bone defects. The titanium fiber mesh is 
shown to be an excellent scaffold material for application for autologous bone grafts. There are 
no adverse effects with the use of PRP since it is autologous and non carcinogenic because the 
proliferative growths are induced by differentiation factors only, not mutagens. 
 
Miguel Gustavo Setubal Andrade et al 
46
( 2008 )Discusses a protocol for obtaining PRP and 
evaluate which factors modify PRP cytometry and coagulation time. Whole blood parameters 
can predict PRP features. Whole blood hematocrit is an important variable for PRP preparation 
and PRP cytometry characterization. PRP platelet count is dependent on whole blood platelet 
count.  Platelet growth factors are able to intensify matrix formation and stimulate osteoblastic 
differentiation. Best biological response occurs when 4 to 5 fold increase over the baseline 
platelet number is achieved. 
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Agata Cieslik- Bielecka et al
47
  ( 2008 )  Other applications of PRP in maxillofacial surgery  
were studied . Basically by concentrating platelets , healing process is stimulated. After platelet 
degranulation there is massive relaease of growth factors.  In this study PRP gel was used for 
mandibular odontogenic cysts. The oral mucosa healed faster in patients treated with this.  
Radiographic features showed considerable enhancement of bone regeneration beginning from 
4
th
 week onwards.  This was the first report that showed the use of PRP in cysts. 
 
Foster TE  et al
48
 ( 2009 ) Autologous PRP is increasingly used in treatment in a variety of soft 
and bony tissue defects. Accelerates bone formation and management of chronic non healing 
wounds.Topical gel was used topically in soft tissue wounds. There was better healing rate and 
adequate tissue regeneration in order to undergo plastic reconstruction. Indicates the use of PRP 
in sports medicine and in the management of tendonitis, tennis elbow etc. 
 
Gilberto Sammartino et al
49
 ( 2009 ) combined autologous platelet rich plasma and resorbable 
membrane for prevention of periodontal defects after deeply impacted mandibular third molar 
extraction. The study with PRP alone versus PRP and bio resorbable membrane  showed similar 
results in bone density, but the latter showed a high degree of bone maturation but not 
regeneration when the studies were carried out histologically. 
 
Emilio Lopez- Vidreiro et al  
50
( 2009 )   Studied the use of platelet rich plasma in arthroscopy 
and sports medicine. Gives the properties of platelet rich plasma. PRP can be used in sports 
related injuries like chronic tendinosis, tendinopathy, osteoarthritis, muscle injury, hamstring 
tears and osteochondritis.  
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Zhen Ming Hu et al
51
 ( 2009 ) The molecular level of platelet rich plasma was evaluated. 
Showed that PRP induces mRNA expression of VEGF and PDGF in bone marrow stromal cell 
differentiation. This study indicates a potential contribution of PRP as the starting process of 
angiogenesis, recruiting the endothelial cells which line blood vessels and beginning the 
initiation of bone regeneration. It jump starts the beginning of a cascade of events that continue 
to form a mature graft.  The addition of PRP to a graft reduces the time period for the 
consolidation of the graft. 
 
Michael P Hall et al
52
  ( 2009 ) Demonstrated the current uses of PRP in the field of sports 
medicine. Explained the various growth factors and the specific function for each of the growth 
factor.  Compared the various PRP therapy preparation systems and evaluated the final 
concentration of platelets derived from each method. Explains the tendon graft healing induced 
by PRP and the effect of PRP in gycosylaminoglycans and chondroitin sulphate. 
 
Volker LW et al 
53
( 2009 ) The objective of this study was to compare the growth factor 
relaease from PRP and PRF in vitro.The study showed that the PRP application in cell cutures 
leads to higher levels of growth factors than from PRF applications. In osteoblasts the cytokine 
concentrations were significantly higher for PRP than PRF. Same results were obtained for 
fibroblast culture too. 
 
Sunitha J et al
54
 ( 2010 ) The study was done using a combination of PRP and hydroxyapatite 
bone graft in the treatment of infra bony defects. Explains the ability of PRP to consolidate the 
bone grafts .  Increased bone ingrowths into a porous hydroxyapatite crystal was demonstrated 
when combined with PRP.  
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Shengyun Huang et al 
55
 ( 2010 ) Studied the influence of platelet rich plasma on proliferation 
and osteogenic differentiation of skeletal muscle satellite cells. The result of the study suggested 
that PRP containing osteoinductive growth factors stimulate cell proliferation and osteogenic 
differentiation of skeletal muscle satellite cells. The Alkaline phosphatase activity was kept as a 
marker for osteoblastic differentiation. 
 
James L Rutkowski et al
56
  ( 2010 ) Explained how PRP facilitated wound healing following 
tooth extraxction. Following  extraction  bone formation normally takes 12 -15 weeks . Stated 
that it took nearly 6 weeks for control extraction sites to reach the bone density achieved at PRP 
sites in 1 week. Also the control sites required 16 weeks to reach the bone density levels as 
reached by the test sites in 8 weeks. Bone densities were measured using Digital subtraction 
radiohrapghy and CT . Also used Image J software for dental radiograph analysis. 
 
Norbert Pallua et al
57
 ( 2010 ) Investigated the application of PRP in burns. Showed 
theoretically the effect of PRP in burn wounds. Currently in burns PRP could stimulate dermal 
regeneration , increase te take rate after skin graft and speed up re-epithelialisation. PRP can be 
mixed with fat  and this has showed a promising result in scar reconstruction. 
 
Bahadir Gurbuzer et al  
58
( 2010 ) Showed the effect of platelet rich fibrin on early bone 
healing process with scintigraphy based on technetium-99m methylene diphoshonate uptake in 
third molar extraction socket. Their study showed that PRF might not lead to enhanced bone 
healing in soft tissue impacted mandibular third molar extraction socket 4 weeks after surgery.  
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Shobha Prakash et al 
3
( 2011 ) Compared the various platelet concentrates right from their 
history beginning with fibrin adhesives. Compares the efficiency , method of preparation , 
growth factor contents , advantages and disadvantages of platelet rich plasma and platelet rich 
fibrin. Also evaluates both their uses in maxillofacial surgery. 
 
Olufemi K Ogundipe et al
59
 ( 2011 ) This study assess the effect of PRP gel on postoperative 
pain, swelling, trismus and bone regeneration on mandibular third molar extraction sockets. The 
mean postoperative pain score ( visual analog scale ) was lower for PRP group . The scores for 
lamina dura, trabecular pattern and bone density were better in PRP groups. Explains how they 
measured the various post operative sequale like trismus and swelling. Radiographically thy 
proved the scores for bone density, lamina dura and trabecular pattern  was better in PRP group. 
The beneficial effects of PRP are more noticeable during the early phase of healing.  
 
Javier Montero et al
60
  ( 2011 ) Evaluates the change in the periodontal status of mandibular 
second molars following the extraction of adjacent impacted third molars. Molar depth seemed to 
be the main factor modulating the baseline probing depth and change in probing depth during 
follow up. Reported that the use of PRP in bone regeneration , afforded a satisfactory reduction 
in pocket depth and a gain in attachment as well as formation of new bone in the bone defect. 
 
Akira Matsuo et al 
61
 ( 2011 )Evaluated the bone quality of mandibles reconstructed with 
particulate cellular bone marrow ( PCBM ) and platelet rich plasma. Deals on the evaluation of 
bone density using computer software. The study indicated both PCBM and PRP yielded same 
bone density. 
 
 
REVIEW OF LITERATURE 
 
23 | P a g e  
 
Kedarnath et al
62
 ( 2011 )Estimated the role of PRP in healing after impacted third molar 
surgery. Elaborately deals with the various growth factors present in PRP and the role of each of 
the factors. Photo stimulating phosphor was used to determine the changes in the IOPA. The 
authors concluded that the PRP contributed to the better healing of soft tissues and bone and is a 
means of growth factor delivery. 
 
Eriko Marakawa et al  
63
( 2011 ) Studied on the reduction of bone resorption by the application 
of platelet rich plasma in bone grafting of alveolar cleft. Satisfactory bone bridging formation 
was seen in PRP treated patients than the control group. The added PRP reduced the resorption 
of  regenerated bone post operatively. The PRP preserves the width and height of the graft 
without resorption. The addition of PRP to autogenous cancellous bone grafts appears to 
significantly reduce post operative bone resorption after one year. 
 
M Del Fabro et al
64
 (2011 )Assess the healing potential of PRP in the healing of extraction 
sockets. Favourable effects on hard and soft tissue healing was noted and post operative 
discomfort reduction was seen. Reduces post operative pain and inflammation. A favourable 
effect on soft tissue healing and post operative discomfort was noted. There has also been a 
reduction in postoperative pain . 
 
MD Batstone et al
65
  ( 2011 ) Studied on the effect of PRP inprevention of osteoradionecrosis. 
PRP failed to show an effect on osteoradionecrosis. There was no effect on mucosal healing and 
pain reduction. 
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Olga Garcia-Martinez et al 
66
 ( 2012 )This study aimed the effect of PRP on the cell cycle, 
antigenic profile, and proliferation of primary cultured human osteoblasts. The treatment of 
osteoblasts with PRP modified the expression of CD 54, CD80 , CD86 and HLA-DR antigens. 
PRP increased cell proliferation in the short term. This study showed that PRP induces neo bone 
formation without any change in cell cycle, thereby proving there is no malignant potential 
involved. 
 
Ronaldo Célio-Mariano et al 
67
( 2012 )There was significantly faster bone formation in sockets 
treated with .Significant bone formation was observed in the first month ,second month  and 
thirdmonth were noted for the PRP group than the non PRP group. The radiographic bone 
density was calculated using the HLIamge ++ software. No statistical differences were observed 
on the seventh day and sixth month of investigation, yet there were higher means of radiographic 
bone density in sockets treated withPRP. In the control group, men exhibited significant bone 
repair compared with women . Autologous PRP was found to accelerate alveolar bone 
regeneration, and men presented better repair after tooth extraction. 
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Materials and methods  
 
Materials and methods: 
This prospective, randomized double blinded control trial was conducted in Rajas  
Dental College and Hospitals, Tirunelveli dist, Tamil Nadu , between January and  
July 2012. This study protocol was approved by the Institutional Review Board  
and Ethical Committee. Informed consent was obtained from all patients.( Annexure I ) 
 
Inclusion criteria 
 
   1. Healthy non diabetic individuals between 18 and 34 years of age. 
2.  Patients having bilaterally impacted mandibular 3rd molars. 
 
3. Absence of pericoronitis . 
 
4. Absence of opposing traumatic occlusion or impinging upper 3rd molars  
 
5.  Patients without any systemic  diseases. 
 
      6. Female patients not on oral contraceptives. 
 
 
 
 
Exclusion criteria 
 
 
1. Recent antibiotics or steroid use. 
 
2. Systemic immunodeficiency , chemotherapy and radiation therapy. 
 
3. Non localized odontogenic infection. 
 
4. Surrounding tissue pathology or lesion. 
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5. Smokers/ alcoholics. 
 
6.Associated medical conditions contraindicating dental extraction. 
 
7.Diabetic history > 10 years ( RBS > 180 mg/dL ). 
 
 
 
Materials  
 
After obtaining the complete history ( Annexure II ), patients were examined clinically and were  
 
explained about the procedure, its complications and the follow-up period involved  
 
in the study. The patients who were willing were enrolled for the study and  
 
preoperative Intra Oral Periapical Radiographs and Orthopantomograms  were  
 
taken. Informed consent was obtained from all patients. 
 
 
 
Sample selection 
 
The study sample consisted of 12 patients, 7 males and 5 females,(chart 1 and 2 ) who presented  
 
with bilaterally impacted mandibular molars and in similar positions. In the 24  
 
impacted teeth, 17 were mesioangular,3 distoangular and 4 vertical , according to  
 
Pell and Gregory classification ( Chart 3 ). 
 
  
 
Study groups 
 
All patients underwent bilateral surgical  removal of impacted 3rd molars .The two  
 
operated sides in each patient were randomly divided into two  study groups: test  
 
and control.  
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Extraction of the impacted mandibular third molar at one side whose socket was 
 
 simply sutured was called the control side, while the opposite impacted third  
 
molar socket ,which was filled with PRP gel and sutured  was called the test side.   
 
PRP , prepared prior to start of the procedure was activated  to form PRP gel .The  
 
sockets where PRP is to be placed  were  randomly selected. Patients were recalled   
 
on first, second day,third day,  first  week, fourth  week and  2 months  
 
postoperatively, for follow up study. 
 
 
 
Preparation of  PRP  gel 
 
 
The PRP was not prepared in this study using the centrifuge. The gel was prepared  
 
from the method introduced by Thrombodyne  Inc, Salt Lake City , Utah, United 
 
 States. The method was described as  Concentrated Autologous Platelet System 
 
 ( CAPS )
68
. This yielded a solution of concentrated platelets in an isotonic medium  
 
without plasma.[ FIGURE I A ] 
 
 
The preparation system is available  as a single use kit with the following contents. 
 
 A vacutainer blood collection kit ( 10 mL ) with a Citrate Phosphate Dextrose  
 
Anticoagulant (CPDA)[FIGURE I B] ,a mixing syringe kit with a 10 mL mixing syringe and a  
 
syringe to syringe coupler, a  filter assembly kit with a 3 way stop cock and a Barb  
 
Leur connector, a rinsing kit with a rinsing syringe, Calcium Chloride ,Sodium  
 
Chloride vial and an amorphous Hydrogel.[FIGURE I C] 
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Using a tourniquet 10 mL blood is drawn from the antecubital region with the  
 
vacutainer kit with  the adaptor connected.[FIGURE I D]The contents in the vacutainer are 
 
 thoroughly mixed and transferred into the mixing syringe using the syringe to  
 
syringe coupler. Now the contents are again mixed inside the mixing syring with  
 
the metal mixer inside it. Approximately 60 inversions of the syringe must be  
 
done. This is done to activate the platelets.[FIGURE I E] 
 
 
Transfer the entire contents in the mixing syringe to the filtering system. [FIGURE I F] 
 
Connect to the 3 way stop cock and the collection kit.Transfer the contents to the  
 
collection kit ( collection bag in the filter assembly).Now the calcium chloride is  
 
mixed with sterile water ( 10% calcium chloride ) and is pushed through the stop  
 
cock to the filter assembly. Sodium chloride is also added to make the solution  
 
isotonic.[FIGURE I G]Now take the recovery kit and the recovery syringe and connect to the 3  
 
way stop cock. Draw the contents from the filter where the platelets have  
 
accumulated. 2 mL of platelet solution is  collected.[FIGURE I H]This is mixed with the  
 
amorphous hydrogel to make it into a gel form.[FIGURE II] 
 
 
Surgical technique[ FIGURE III- ARMAMENTARIUM ] 
 
All the cases were done under conscious sedation with intravenous Midazolam  
 
upto 5 mg with monitoring of blood pressure and oxygen saturation using a  
 
multiparameter. Inferior alveolar nerve block, lingual nerve block and long buccal  
 
nerveblock were administered using 2% lignocaine hydrochloride with 1: 2,00,000  
 
adrenaline, standard Ward’s incision was followed in all the cases. Full thickness  
 
mucoperiosteal flap was raised to expose sufficient bone on lateral and distal 
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aspect of the impacted molar. Removal of bone was done with 702 carbide bur.  
 
 
Constant irrigation was done with normal saline while removing bone to prevent   
 
thermal necrosis. Surgical removal of impacted tooth was done. The surrounding  
 
bone was smoothened. The wound was gently irrigated with sterile saline solution 
 
and checked  for any small detached fragments of bone or tooth pieces. Surgical   
 
removal of impacted mandibular 3rd molar was done on the opposite side in the  
 
similar way and one of the extraction socket was randomly chosen by the operator  
 
for PRP placement. 
 
 
 
PRP placement [FIGURE IV] 
 
The pre processed PRP was taken into the sterile stainless steel bowl and 0.5ml of  
 
CaCl2 was mixed to obtain the PRP gel, which was placed into the selected  
 
extraction socket  and primary closure of the wound was done . No graft material  
 
was added to PRP in this study. Wound was closed with a 3-0 black braided silk  
 
interrupted suture. [FIGURE V,VI.VI A &B AND VII] 
 
 
Pressure packs were given and the normal post extraction instructions were given. 
 
The patients were adviced amoxicillin 500 mg thrice daily and diclofenac 50 mg  
 
thrice daily for three days. All the patients were given dexamethasone 2mg  
 
intravenously after the procedure. All were adviced  chlorhexidine mouthwash  
 
four times a day for one week. 
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First, third and seventh post operative day 
 
Evaluation for pain , soft tissue healing alveolar osteitis. 
 
Post operative IOPA and OPG was taken on the seventh day.[FIGURE VIII A] 
 
Sutures were removed on the seventh day. 
 
 
 
 
4 weeks post operatively 
 
Evaluated for pain and soft tissue healing 
 
IOPA and OPG taken 
 
 
 
8 weeks post operatively 
 
Evaluated for pain and soft tissue healing 
 
IOPA and OPG taken.[FIGURE VIII B] 
 
 
 
Clinical evaluation 
 
Clinical evaluation included assessment of pain, swelling, soft tissue healing ,  
 
bone density and alveolar osteitis. 
 
 
 
Pain 
 
Describes the evolution of self-reported pain measured in a visual analogue scale  
 
(VAS) in the first 7 days after extraction.. A 10-point visual analog scale (VAS) 
69 
 
with a score of 0 indicating “no pain” and 10 indicating  “very severe pain” was  
 
used to assess pain on post operative days 1 , 3 and 7. 
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Visual analogue scale ( VAS ) – intraoperative  pain intensity ( Annexure IV ) 
 
The scoring criteria is as described below : 
 
0 = absolutely no pain 
 
1= very mild pain 
 
2-4 = mild pain 
 
5-7= moderate pain 
 
8-9 = severe pain 
 
10= unbearable pain 
 
 
Swelling 
70 
 
 
Swelling was assessed using 5 fixed points on surgical side of the face and finding  
 
the average. The fixed points used  were; the most posterior point at the midline on  
 
the  tragus ,lateral canthus of the  eye,  the most lateral point on the corner of the  
 
mouth,  soft tissue pogonion  which  is the most prominent point at the midline on 
 
 the chin and  most inferior point on  the angle of the mandible. Three lines are  
 
drawn joining the points .[A,B andC] The sum of the measures of the  3 lines are found out . A  
 
baseline measurement was carried out just before the  surgery and similar  
 
measurements  were carried out on second and seventh day post operatively. The  
 
difference between the  postoperative and preoperative  measurements was  
 
calculated.  ( swelling post op –  swelling pre op ). This method  was described by  
 
Yakup Ustun  et al. [FIGURE IX.A AND IX. B] 
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Soft tissue healing
71 
 
 
Evaluation of soft tissue healing by Landry , Turnbull and Howley. 
 
 
Healing index 1 :very poor and has 2 or more of the following  
 
 
Tissue colour > 50 % of the gingival red 
 
Response to palpation – bleeding 
 
Granulation tissue -present 
 
Incision margin- not epithelialised with loss of epithelium beyond the incision  
 
Margin 
 
 
Healing index 2 : poor 
 
 
Tissue colour > 50 % of gingiva red 
Response to palpation – bleeding 
 
Granulation tissue present 
 
Incision margin – not epitheliailsed with exposure of connective tissue 
 
 
Healing index 3 : good 
 
 
Tissue colour > 25% < 50 % gingival red 
 
Response to palpation –no  bleeding 
 
Granulation tissue none 
 
Incision margin – no connective tissue exposed 
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Healing index 4 : very good 
 
 
Tissue colour > 25%  gingival red 
 
Response to palpation –no  bleeding 
 
Granulation tissue –none 
 
Incision margin – no connective tissue exposed 
 
 
Healing index 5 : excellent 
 
Tissue colour – all tissue pink 
 
Response to palpation –no  bleeding 
 
Granulation tissue –none 
 
Incision margin – no connective tissue exposed  
 
 
Radiographic evaluation for bone density 
 
 
Orthopantomograms  were taken preoperatively,at the first and eighth  week  
 
respectively to assess and compare radiographic bone densities between PRP and  
 
non PRP sites. The radiographic bone densities were evaluated by Adobe Photoshop 
 Software. The bone densities could be measured at the alveolar crest levels, furcation level and 
the apical region of the surgically removed mandibular third molars. In the present study the 
apical region of the removed molars were taken to measure the bone densities. 
 
Orthopantomogramic images were digitalized using the Sidexis software. The  
 
image was transferred  to  Adobe Photoshop. The grey scale values were  
 
measured.  The grey scale values were compared at the PRP and non PRP sides in  
 
the same OPG. The values were noted. [FIGURE X A &B] 
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Assessment for alveolar osteitis 
 
 
Assessment was done on the third day postoperatively. Patient was asked if they experienced  
 
increasingly severe pain in and around the extraction socket. The socket is checked for necrotic  
 
odour or grayish discolouration. The pain experienced during alveolar osteitis or dry socket is  
 
refractory to the post operative analgesics .  
 
 
 
All the values and scores obtained for the parameters described above were recorded in the  
 
patient data form ( Annexure III ).  This was done by an investigator who did not know the test  
 
and the control side. The values and scores thus obtained were tabulated  [ pain assessment –  
 
table I, soft tissue healing score – table II, gray value scales at the end of first week and second  
 
month respectively – table III a and III b , swelling assessment – table IV and assessment of  
 
alveolar osteits – table V ). 
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ARMAMENTARIUM 
FIGURE I  A . Platelet Concentration Kit 
 
    
 
 
 
  
 
FIGURE I B. Blood collection kit ( vacutainer ) 
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FIGURE  I  C . Rinsing kit                                                                
 
 
 
 
 
 
FIGURE I D.  blood drawn from patient            FIGURE I E. Blood and Anticoagulant 
mixed 
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FIGURE I F. Filter assembly                        FIGURE  I G. addition of sodium chloride 
 
                 
                                                   
 
 
FIGURE I H. Filtering the platelet concentrates      FIGURE II   Final platelet concentrates 
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FIGURE III. Armamentarium for impaction surgery 
 
 
 
 
 
FIGURE IV.Platelet concentrates mixed with hydrogel                                               
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FIGURE V. Extracted socket 
   
 
 
 
VI.A Placement of the platelet concentrates into the socket 
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VI B. Socket irrigated 
 
 
 
VII. Socket primarily sutured  
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VIII A.OPG taken in the first week            
 
PRP was placed on the right side. The difference in gray values are noted 
 
VIII B. OPG taken after 2 months 
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FIGURE IX A. Assessment of swelling ( PRP side was on the left while the non PRP side 
was the right ) 
Assessment done on the third day 
 
 
 
FIGURE IX B.  Yakup Ustuns swelling assessment 
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FIGURE X A. gray scale value at the left impacted tooth socket. 
 
 
FIGURE X B. Gray scale value at the right impacted tooth socket. 
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Results  
 
No patient was lost to follow-up. Pain, edema, and limited mouth opening were  
 
well controlled in the postoperative period with the drug protocol established. 
 
There were spontaneous reports of patients who noticed mild alterations in facial  
 
volume at one  side, which corresponded to the side of the PRP group. There was  
 
no excessive bleeding at any side. 
 
 
The study consisted of totally 12 patients who reported to Rajas Dental College   
 
and Hospital . Following completion of the clinical study ,measurements and data  
 
were taken from patients on their post operative follow up. This was a randomized  
 
double blinded control trial study. The results and outcomes were checked by  
 
another investigator to avoid the bias. 
 
 
After analysis of the data , the following observations were made. There were 7  
 
male patients and 5 female patients. They were in the age of 18 – 35 years and the  
 
mean age was 25.16 
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Results of clinical assessment 
 
 
Assessment of pain 
 
 
Assessment of pain by visual analogue scale on first post operative day showed  
 
mean pain score of  2.91  at the test site and 4.16 at the control site ( P value –  
 
0.002 ). On the third  day the mean score on the test site was 2.33 while that on the  
 
control site was  2.91 ( P value 0.091 ). On the seventh post operative day the mean  
 
on the test site was 0.58 while on  the control side was 0.91.(P value  0.293 ). 
 
It was seen that the values obtained for PRP side was statistically significant than  
 
non PRP sides in respect to pain.  Thus pain was considerably less for the test  
 
group than the control post operatively. 
 
 
 
Assessment of soft tissue healing 
 
 
The soft tissue healing assessment was based on the criteria set by Landry and  
 
 Turnbull. The mean value  of the healing assessment was done in the first post  
 
operative day and was found to be 3.0  in the control side and 3.08 in the test side  
 
9(P  value  0.77). On the third post operative day the mean was 3.91 for the control  
 
side  and 3.41 for the  test side ( P value 0.330 ). One the first week post  
 
operatively it  was seen that the mean for the test side was 4.75 while that for the  
 
control side was  4.6.( P value 0.397 ). Though the test group exhibited better soft  
 
tissue healing , the values obtained showed it was statistically insignificant. This  
 
was probably due to the  small sample size. 
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Assessment of gray value scale 
 
 
This was done using the Adobe Photoshop software. The gray value for this study  was  
 
done in the apical region of the surgically removed third molars.  The mean value  
 
obtained  for the gray value scale for the control side was 140.91 and for the test  
 
side was 128.63 ( P value 0.054). The mean value of the gray scale obtained at the  
 
end of the first  month was 145.58 for the control side and 133.58 for the test side    
 
( P value 0.029 ). The values obtained for the bone density for the control and the  
 
test side showed that PRP created  a statistically  significant difference . 
 
 
Assessment of swelling  
 
Assessment of swelling as done by Yakup Ustin  was done on the second  and  seventh post  
 
operative day. The mean of the swelling values on the second post  operative day was 6.33 on the  
 
control side and 6.39 on the test side (P value 0.82).  On the seventh post operative day it was  
 
seen that the mean value on the test side  was 3.1 while on the control was 3.2 (P value 0.71  ).   
 
This was statistically  significant. Thus PRP  did not have any statistical significance  on   
 
swelling on  test  side. 
 
 
Assessment of alveolar osteitis 
 
Examination for dry socket was done on the third day postoperatively. None of the sockets  
 
presented with dry socket. Neither the control nor the test side showed dry socket. ( Table V ).  
 
This showed that as per the study, PRP did not have any effect on dry socket.  This may be due  
 
the limited sample size. But other studies have shown the efficiency of platelet concentrates in  
 
the reduction of dry socket 
39
. 
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Pain assessment ( Table 1 ) 
Days First day Third day Seventh day 
Sl no Test Control Test Control 
Test 
 
Control 
 
1 3 4 2 2 0 2 
2 3 4 2 4 1 1 
3 4 3 3 4 0 0 
4 3 5 2 4 1 1 
5 2 5 2 3 0 0 
6 2 6 1 4 0 2 
7 3 4 2 3 1 2 
8 4 3 4 2 1 0 
9 3 3 3 2 1 1 
10 3 5 2 4 1 1 
11 3 4 2 2 0 0 
12 2 4 3 2 1 1 
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Soft tissue healing  ( Table II ) 
Sl no 
First day Third day Seventh day 
Test Control Test Control 
Test 
 
Control 
 
1 3 3 4 4 5 4 
2 3 3 4 4 5 5 
3 3 3 4 4 5 5 
4 4 4 4 4 5 5 
5 3 3 4 4 5 4 
6 3 3 4 4 5 5 
7 3 3 4 4 5 5 
8 2 2 3 4 4 4 
9 4 3 4 3 4 4 
10 4 4 5 3 5 5 
11 2 4 2 3 5 5 
12 2 2 5 4 4 4 
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( Table III a ) 
 
Gray value scale ( at one week ) 
Sl no 
 
Test Control 
1 164 141 
2 159 132 
3 118 98 
4 126 120 
5 151 143 
6 116 130 
7 123 116 
8 138 112 
9 141 130 
10 150 141 
11 159 141 
12 143 132 
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( Table III b ) 
 
Gray value scale ( at 2 months ) 
Sl 
no 
 
Test Control 
1 166 147 
2 161 138 
3 133 108 
4 128 124 
5 159 147 
6 126 133 
7 133 129 
8 139 131 
9 144 131 
10 151 139 
11 162 143 
12 145 133 
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Swelling assessment ( Table IV ) 
 
Days Second day Seventh day 
Sl no Test (mm) Control(mm) Test (mm) Control(mm) 
1 7.9 7.9 3.0 3.0 
2 6.8 6.5 3.0 3.2 
3 5.7 5.9 2.7 3.0 
4 6.2 6.5 4.2 3.3 
5 6.8 6.9 3.4 3.2 
6 5.5 5.4 3.3 3.7 
7 5.6 5.2 3.2 3.2 
8 5.4 5.9 2.9 2.9 
9 7.9 8.0 3.3 3.3 
10 7.5 6.6 4.0 3.7 
11 6.7 8.0 3.0 2.9 
12 7.6 7.9 2.9 2.8 
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Assessment of alveolar osteitis ( Table V ) 
 
Sl no Test Control 
1 Nil Nil 
2 Nil Nil 
3 Nil Nil 
4 Nil Nil 
5 Nil Nil 
6 Nil Nil 
7 Nil Nil 
8 Nil Nil 
9 Nil Nil 
10 Nil Nil 
11 Nil Nil 
12 Nil Nil 
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Gender distribution ( chart 1 ) 
 
 
 
 
 
 
 
 
 
 
males females
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Age distribution ( Chart 2 ) 
 
20
21
22
23
24
25
26
27
males
females
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Distribution of impaction ( chart 3 ) 
 
 
 
0
2
4
6
8
10
12
14
16
18
mesioangular vertical
type of
impaction
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Assessment of pain using visual analogue scale ( Chart 4 ) 
 
 
 
 
 
 
  
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
first day second day third day
mean pain 
score
Test
Control
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Assessment of bone density  using  gray value scale ( chart 5 ) 
 
120
125
130
135
140
145
150
gray value 
scale
first week second month
Test
Control
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Assessment of soft tissue healing by Landry and Turnbull ( Chart 6 ) 
 
0
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1
1.5
2
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3
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4
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Assessment of swelling  ( chart 7 ) by Yakub Ustin 
0
1
2
3
4
5
6
7
second day seventh day
Test
Control
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Statistics  
Pain assessment 
Mann Whitney U test 
Test statistics  
 
Test statistics Pain score (day 
1) 
Pain score  (day 
3 ) 
Pain score (day 7 
)  
Mann Whitney 
 U 
 
21.500 45.000 55.500 
Asymp. 
Significance (2 
tailed ) 
0.002 0.091 0.293 
 
P value at day 1 = 0.002, at day 3 = 0.091, at day 7 = 0.293 
 
Non parametric tests 
 
Descriptive statistics 
 N mean Std. 
deviation 
mininum maximum 
Day 1 24 3.5417 1.0206 2.00 6.00 
 
Day 3 24 2.6667 0.916 1.00 4.00 
 
Day 7 24 0.7500 0.675 0 2.00 
 
category 24 0.50 0.511 0 1 
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Ranks  
Category  y N Mean rank Sum of ranks 
Day 1    0 
             1 
              total 
12 
12 
24 
16.71 
8.29 
200.50 
99.50 
 
 
Day 3   0 
             1 
             total 
12 
12 
24 
14.75 
10.25 
177.00 
123.00 
 
 
Day 7    0 
             1 
             total 
12 
12 
24 
13.88 
11.12 
166.50 
133.50 
 
 
 
 
Test statistics 
b 
 
Day 1 day 2 Day 3 
Mann-Whitney U 
Wilcoxon W 
Z 
Asymp. Significance 
( 2 tailed ) 
Exact significance  
[ 2
*
(1 tailed 
significance )] 
21.500 
99.500 
-3.073 
 
0.002 
 
 
0.002
a 
45.000 
123.000 
-1.689 
 
.091 
 
 
0.128
a 
55.500 
133.500 
-1.051 
 
0.293 
 
 
.347
a 
 
a -not corrected for ties 
b- Grouping variable:  category 
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Soft tissue healing assessment  
 
Mann Whitney U Test 
 
Test statistics  
 
Test statistics first day Third day Seventh day 
Mann Whitney U 
 
 
67.500 58.500 60.000 
 
 
 
Asymp . Significance 
( 2 tailed ) 
0.774 0.330 0.397 
 
 
 
 
Non parametric tests 
Descriptive statistics 
 
 N Mean Std. Deviation minimum maximum 
Day 1 
 
Day 3 
 
Day 7 
 
category 
24 
 
24 
 
24 
 
24 
3.0417 
 
3.8333 
 
4.6667 
 
0.50 
0.69025 
 
0.63702 
 
0.48154 
 
0.511 
2.00 
 
2.00 
 
4.00 
 
0 
4.00 
 
5.00 
 
5.00 
 
1 
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Ranks  
Category y N Mean Rank Sum of ranks 
Day 1        0 
                  1 
                  total 
12 
12 
24 
12.88 
12.12 
154.50 
145.50 
Day 3        0 
                 1 
                 total 
12 
12  
24 
11.38 
13.62 
136.50 
163.50 
Day 7       0 
                 1 
                total 
12 
12 
24 
11.50 
13.50 
138.00 
162.00 
 
 
Test statistics
b 
 Day 1 Day 3 Day 7 
Mann Whitney 
 
Wilcoxon W 
 
Z 
 
Asymp significance ( 
2 tailed ) 
 
Exact significance 
[ 2
*
(1 tailed 
significance )] 
67.500 
 
145.500 
 
-o.287 
 
 
0.774 
 
 
 
0.799
a 
58.500 
 
136.500 
 
-0.974 
 
 
0.330 
 
 
 
0.443
a 
60.000 
 
138.000 
 
-0.848 
 
 
0.397 
 
 
 
0.514
a 
 
P value =0.774 at day 1,  0.330 at day 3  and 0.397 on day 7 
a- Not corrected for ties 
b- Grouping variable : category 
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Assessment of grey scale value 
 
T- test  
test statistics 
 
 
 
 t difference Significance 
Grey value at 
first week 
2.032 22 0.054 
 
 
 
Grey value at 
second month 
2.341 22 0.029 
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Swelling assessment 
t – test 
test statistics 
 
 
 
 t difference significance 
Swelling  ( day 2 ) -0.227 22 0.822 
 
 
 
Swelling  ( day 7 ) 0.377 22 0.710 
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Group statistics for grey scale and swelling 
T Test 
Category y N Mean Std .Deviation Std error mean 
Grey1          0 
                     1 
 
12 
12 
1.4067E2 
1.2800E2 
16.49426 
13.93491 
4.76148 
4.02266 
Grey 2         0 
                     1 
 
12 
12 
1.4558E2 
1.3358E2 
14.10641 
10.78263 
4.07219 
3.11268 
Swelling 2    0 
                     1 
 
12 
12 
 
6.6333 
6.7250 
0.94804 
1.02702 
0.27368 
0.29648 
Swelling 7   0 
                     1 
12 
12 
3.2417 
3.1833 
0.45017 
0.29181 
0.12995 
0.08424 
 
 
 
P value for soft tissue healing on second day is 0.822 and on the seventh day is 0.710 
P value at first week for bone density is 0.05 and at second month is 0.029 
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Discussion  
Platelet  rich plasma has been a breakthrough in the stimulation and acceleration of  bone and 
soft tissue healing. It represents a relatively new biotechnology that is part of a growing interest 
in tissue engineering and cellular therapy today. 
Platelet rich plasma gel functions as a tissue sealant and a drug delivery system that contains a 
host of powerful mitogenic and chemotactic growth factors. Haemostasis is achieved through the 
formation of a fibrin clot that is initiated by the activation and aggregation of platelets. Beyond 
maintaining haemostasis,the fibrin clot  provides a matrix for the migration of tissue forming 
cells and endothelial cells involved in angiogenesis and the remodelling of the clot for tissue 
repair.Using PRP involves, taking sample of patients blood preoperatively , concentrating the 
autologous platelets and applying the resultant gel to the surgical site. Surgical sites which were 
treated with PRP has shown to heal 2- 4 times faster than normal sites. PRP is activated to form 
PRP gel causing degranulation of the α granules to release the growth factors. 
PRP can be defined as a volume of autologous plasma that has a platelet concentration above the 
base line. Normal platelet count in blood ranges from 1,50,000  to 4,00,000 / µL. Since the 
scientific proof of bone and tissue healing has been shown using PRP with 10,00,000 platelets / 
µL it is this concentration of platelets in a 5 mL volume of plasma. 
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Platelet concentration ratio 
The  effect of platelet rich plasma on wound healing depends on what is likely a function of 
many variables, which includes the platelet concentration , volume of PRP delivered, extend and 
type of injury ,and the overall health status of the patient. 
 
The working definition of PRP is 10,00,000/µL with lesser concentrations unable to be relied on 
to enhance wound healing and greater concentration not known to provide further enhancement.  
Several authors have  stated that the aim is to prepare PRP with a platelet count in excess of 
3,00,000 /µL . It was later concluded that the beneficial effects of platelet rich plasma would be 
well noted if the concentration  of platelets ranged between 3- 5 times over the baseline. 
 
Platelets are cytoplasmic fragments of megakaryocytes, a type of white blood cell, and are 
formed in the marrow.They are the smallest of the blood cells, round or oval in shape, and 
approximately 2 µm in diameter.The cell membrane is trilaminar with glycoprotein receptor 
surface overlying and partiallyinterspersed with a  penetrating  bilayer of phospholipids and 
cholesterol. They lack nuclei but contain organelles and structures such as 
mitochondria,microtubules, and granules (alpha, delta, and lambda).The α granules33, bound by a 
unit membrane, are formed during  megakaryocyte  maturation. Platelets reside intravascularly, 
with high concentration in the spleen. The platelets remain in the circulation for an average of 
about 10 days before removal by macrophages of the reticuloendothelial system. 
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Activation causes the α  granules to fuse to the platelet cell membrane (also called degranulation) 
where at least some of the secretory proteins (eg, PDGF and TGF-β) are transformed to a 
bioactive state by the addition of histones and carbohydrate side chains. The active proteins are 
then secreted, binding to transmembrane receptors of target cells (eg, mesenchymal stem cells, 
osteoblasts, fibroblasts,endothelial cells, and epidermal cells). These agonist bound 
transmembrane receptors activate an intracellular signal protein that causes the expression ofa 
gene sequence that directs cellular proliferation, matrix formation, osteoid production and 
collagen synthesis. The active secretion of these proteins by platelets begins within 10 minutes 
after clotting, with more than 95% of the presynthesized  growth factors secreted within the first 
hour. 
 
 
Since PRP is developed from autologous plasma, it is inherently safe and free from transmissible 
diseases like HIV and hepatitis .  Within PRP  the increased number of  platelets delivers an 
increased number of growth factors to surgical area. The growth factors present are
5
 : 
 
PDGF αα- Platelet Derived Growth Factor. 
PDGF ββ 
PDGF αβ 
TGF β1- Tissue Growth Factor 
TGF β2   
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VEGF- Vascular Endothelial Growth Factor 
 EGF – Epidermal Growth Factor 
CTGF – Connective Tissue Growth Factor 
FBF – Fibroblast Growth Factor 
KGF- Keratinocyte Growth Factor 
 
G/MCSF- Granulocyte/Macrophage Colony Stimulating Factor 
TNF α – Tumour Necrosis Factor 
 
Thus PRP is a combination of 7 growth factors with the normal clot as carrier. The clot is 
composed of fibronectin, fibrin and vitronectin which are cell adhesion molecules required for 
cell migration as well as in osteoconduction ,wound epithelialization and osseointegration. 
PRP acts on fibroblasts to increase their number ( mitogenesis ) and stimulate vascular ingrowth 
( angiogenesis ).PRP is best developed from autogenous whole blood shortly or at the beginning 
of surgical procedure. Once developed , PRP is stable and remains sterile in the anticoagulated 
state for 8 hours. 
 
Platelet concentrates may contain small amounts of leukocyte that synthesise interleukins , 
involved in the non specific immune reaction. In the recent years several regenerative procedures 
such as grafting the socket with autologous bone or bone substitutes along with platelet 
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concentrates have been developed.  The growth factors are known to emerge  from degranulating 
platelets at the time of injury. Its mechanism is to activate the cell membrane receptors in the 
target cells, which in turn are thought to develop high energy phosphate bonds on internal 
cytoplasmic signal proteins to initiate a specific activity within target cells. 
 
The most important specific activities of the growth factors include mitogenesis, angiogenesis ( 
endothelial mitosis into functioning capillaries ) and macrophage activation . 
 
Function of each growth factor 
 
The transforming growth factor β ,when released by platelet degranulation acts as a paracrine 
growth factor ( ie growth factor secreted by one cell exerting its effect on the adjacent second 
cell ) affecting mainly fibroblasts, marrow stem cells and preosteoblasts. This growth factor  
presents a mechanism for long termhealing and bone regeneration molecule and even evolve into 
a bone remodeling factor  over time. In addition TGF β inhibit osteoclast formation and bone 
resorption, thus  favouring  bone formation over resorption. The most important function of TGF 
β1 and β2 are  chemotaxis , mitogenesis as osteoblast precursors and have the ability to stimulate 
osteoblast deposition of collagen  matrix for healing of bone. 
 
Platelet derived growth factor ( PDGF ) is chemotactic for polymorphonucleocytes, 
macrophages, fibroblasts and smooth muscle cells. PDGF also stimulates cell replication of 
important stem cells for fibroblasts and endothelialcells (increasing budding of new capillaries), 
stimulates production of fibronectin a cell adhesion molecule used in cellular proliferation and 
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migration during healing, including osteoconduction and hyaluronic acid and helps bring about 
woundcontraction and remodelling. Chondrocytes, osteoblasts and periosteal cell growth 
is up regulated by this factor. α and β isoforms are potent mitogens for fibroblasts, arterial 
smooth muscle cells, chondrocytes, and epithelial and endothelial cells. Potent chemoattractant 
for hematopoietic and mesenchymal cells, fibroblasts,and muscle cells, stimulates chemotaxis 
toward a gradient of PDGFActivates TGF-β, stimulates neutrophils and macrophages, 
mitogenesis offibroblasts and smooth muscle cells 
5,7
. 
 
 
Insulin like growth factor functions as the key regulator of cell metabolism and growth , 
stimulates proliferation and differentiation of osteoblasts.  Growth factor for normal fibroblasts, 
mitogenic in vitro for a  number of mesodermal cell  types.Promotes the synthesis of collagenase 
and  prostaglandin E2 in fibroblasts.   Stimulates collagen and matrix synthesis by bone cells, 
regulating the metabolism of joint  cartilage. 
 
 Vascular endothelial growth factor ( VEGF ) regulates angiogenesis. Stimulates the proliferation 
of macrovascular endothelial cells.A strong angiogenic protein which induces  eovascularisation. 
Induces the synthesis of metalloproteinase, which degrades interstitial  collagen type I, II, and 
III. 
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Epidermal growth factor ( EGF ) regulates cell proliferation, differentiation and survival.  
Stimulates the proliferation of epidermal and epithelial cells, fibroblasts, and  embryonic cells. 
Chemoattractant for fibroblasts and epithelial cells  Stimulates re-epithelialization, augments  
angiogenesis. Influences the synthesis and turnover of extracellular matrix 
5
. 
 
Connective tissue growth factor induces the proliferation, migration, and tube formation of 
vascular endothelial cells and angiogenesis . A potent stimulator for the proliferation and 
differentiation of osteoblasts,stimulates the matrix mineralization. 
 
Tumour necrosis factor is a growth factor for fibroblasts . Promotes angiogenesis 
 
Granulocyte/ macrophage colony stimulating factor stimulates proliferation and differentiation of 
osteoblasts.Synergizes the proliferation of bone morphogenic  progenitor cells. Strong 
chemoattractant for neutrophils. 
 
Keratinicyte growth factor is the most potent growth factor for skin keratinocytes,playing a role 
in tissue repair following skin injuries.  Promotes wound healing via proliferation, 
differentiation,angiogenesis, and cell migration.Mitogen for many epithelial cells but not for 
fibroblasts and endothelial cells 
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Conventional Processing technique 
 
When anticoagulated blood is centrifuged , three layers become evident. Under all  aseptic 
techniques, blood is drawn  intravenously from the anticubital regionof  patients forearm using 
vacutainer needle and vacutainers  containing  CitratePhosphate Dextrose Anticoagulant (CPDA 
,0.8ml each). This anticoagulant is preferred  because it preserves the platelet membrane 
integrity. Growth factors are extruded from the platelets by exocytosis. The protein molecule 
given off attains a tertiary structure. Fragmented platelets gives off more growth factors into the  
solution providing higher levels , but if the structure is altered, the effectiveness of  
these growth factor decreases. 
 
The Vacutainers were thoroughly shaken to ensure maximum mixing of the  anti coagulant with 
the drawn blood. The anticoagulant avoids platelet degranulation and activation. First 
centrifugation is called as soft spin which allows blood separation into three layers . The layers 
are bottom most layer (RBC 55% of total volume), top most acellular plasma ( 40% of total 
volume ) and intermediate layer  ( 5% of total volume ) which is called as buffy coat layer. The  
platelet poor plasma, platelet rich plasma and some  RBCs are transferred into another tube 
without anticoagulant.  
 
This tube will now undergo second centrifugation which is longer and faster than the first. This 
is called as the hard spin. This allows the platelet to settle at the bottom of the tube with very 
little RBC, which explains the red tinge of the PRP preparation. The acellular PPP ( 80 %  of the 
total volume ) is found at the top. Most of this platelet poor plasma  is removed with the syringe 
and is discarded and the remaining  PRP is shaken well. The PRP is then mixed with bovine 
thrombin and calcium  chloride at the time of application. This results in gelling of 
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the concentrate. Calcium chloride nullifies the effect of the anticoagulant . The  
thrombin helps in activating fibrinogen to fibrin and then cross linking . 
 
 
This forms the basis of preparation of PRP with the yield  approximately 10 % of  
the volume of the whole blood drawn. It is important that the procedure avoids  
fragmenting the platelets. Because it is this process of activation that results in  
completion of tertiary structures of some secretory proteins , fragmentation would  
result in release of high levels but with compromised activity. 
 
 
Difference between the conventional technique and the technique used in the study 
 
 
Centrifuge was not used in this method . So it was comparatively less time  
consuming and cost effective. This can be done as a chair side procedure, and  
blood handling , pipetting  out the platelet poor plasma was avoided . There  was  
also no caution with respect to the asepsis to be followed while centrifuging .The 
anticoagulant used in both the methods were same.  
 
The end product while using this method yielded a concentrate of platelets , which  
are lysed , rich in growth factors in an isotonic medium. The plasma has been  
filtered off. So there was no need to activate the platelets using bovine thrombin. 
 There has been several studies which proved the disadvantages of using bovine  
thrombin as an activator. Bovine thrombin factor Va may be a contaminant in  
certain bovine thrombin preparations. Antibodies to bovine thrombin Va may cross 
 react with human factor Va which may lead to coagulopathies and rare bleeding  
episodes
3
. 
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Only calcium chloride was used here to minimize the effect of the anticoagulant. 
Sodium chloride was used here to keep the platelet concentrates in an isotonic  
medium. Thus the end product was activated platelets with the growth factors in an 
isotonic medium. So this method has been found to be much cost effective, less time consuming , 
without any use of chemicals for activation and very simple to use.  
 
In various oral surgical procedures, it was highlighted that the advantages of the  
platelet concentrates on early soft tissue healing might effectively reduce post  
operative inflammation and pain. In addition there was an increase in  
epithelialization, and  decrease in the rate of alveolar osteitis. PRP also has an  
important  part  in the reduction of post operative pain and inflammation. 
 
  
Uneventful and enhanced wound healing is desirable  and critical in ascertaining 
quality of life after third molar surgery. This study examined the effects of PRP gel  
on post operative pain and swelling as well as soft tissue healing and bone regeneration potential 
in third molar extraction sockets.  
 
Some investigators have  reported significant improvements in tissue healing and  
bone formation using PRP, whereas others did not observe improvement. Such  
 discrepancies are  probably related to the lack of suitable standardization of  
definition of the  different PRP preparations.  The protocols and biological  
techniques used in the  elaboration and administration of PRP differ widely.  
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Variations in some key properties of PRP, including platelet concentration, type of  
clot activator,  leukocyte content, and the time that the fibrin scaffold is put into  
place around the  tissue after clotting has started, can influence the different  
biological effects markedly. 
 
 
 
 
Influence of PRP on bone density at the extraction site 
 
 
Orthopantomograms revealed that the effects of PRP were significantly beneficial for increasing 
bone density  following surgery. The increase in bone density suggests a greater volume of new  
bone formation with PRP treatment. Moreover, the increase in bone density (presumed as 
increased volume of new bone formation) was found to occur at earlier time points than non-PRP 
treated control sites. This corresponds with results from molecular studies that demonstrated PRP 
treatment of human  mesenchymal stem cells induced ,early proliferation of these cells and  
possibly differentiation into  osteoblasts. Accelerated bone formation  is in contrast to the drop in 
bone density (representing bone loss) seen at the control site before bone formation began to take 
place. It took approximately 6 weeks for the control sites to reach the same bone density that the 
PRP-treated site had reached by first week. 
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As per the results in this study  it was seen that the bone density at the PRP site was far more 
than the non PRP site at the end of first week and the fourth week.  The values obtained  at the 
end of the first week showed a marked increase in the  rate of new bone formation than in the 
fourth week. Bone density was more in the PRP side when compared with the non PRP side at 
the end of first week and fourth week respectively. The maximum effect was seen in the first 
week .This was because the activity of the growth factors take place more in the first week. 
The maximum growth factors are released during the first week. 
 
 
The control sites required 16 weeks to reach the same degree of radiographic  
density for the total extraction socket as the PRP treatment achieved in 8  
weeks
56
. This is of clinical significance because it indicates more rapid healing at  
the PRP treated sites. Patients who undergo complete maxillary or mandibular   
extractions and are in need of immediate prostheses can benefit from PRP  
treatment. PRP treatment at the time of tooth extraction may permit dental  
implants to be placed at a 2 to 4 month time interval, decreasing the time to  
 implant placement by half. 
 
 
The PRP was placed in the extraction socket (bony defect) with the aim to preserve  
the bony quantity, treat the periodontal pocket, improve bone vertical dimension  
for future implant placement and to promote soft tissue healing by using the  
patients own blood to generate the growth factor. The mechanism by which PRP  
 influences regeneration has been attributed to the presence of PDGF and  
TGF-β1 . PDGF acts principally on osteoblastic proliferation and  TGF-β1  act as  
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cellular  differentiation agents favoring the expression of markers of mineralization  
when incubated with pre-osteoblastic cells. This suggests that TGF-β1 could favor  
the differentiation of osteoblasts and the production of fibronectin, a molecule  
involved in the adhesion of osteoblasts and the  angiogenic process. As a result of  
this fibrin content, the PRP gel permits stabilized coagulation of the blood, thus  
favoring regeneration of the osseous defect, particularly in the early stages.  P value at the end of 
1
st
 week was 0.05 and P value at the end of second month was 0.029.  Both the values were 
clinically significant and showed that PRP has beneficial effect on improvement of bone density 
 
 
 
The influence of PRP on alveolar osteitis 
 
 
The beneficial effects of PRP for decreasing the incidence of alveolar osteitis may  
be related to a number of signaling proteins found in the platelets, including   
multiple growth  factors such as insulin-like growth factor, vascular endothelial  
growth factor, epidermal growth factor, nerve growth factor, transforming growth  
factors β1 and  β2 (TGF-β1), platelet-derived growth factors, and cytokines such as  
angiopoietin-2 and interleukin-1. 
 
These factors stimulate cell mitosis and differentiation, increase collagen  
production, recruit leukocytes and other cells to the surgical site, and initiate  
vascular in-growth. Growth factors promote both soft , hard tissue healing and  
angiogenesis. In addition, platelets promote clot formation, which is beneficial in  
healing. PRP also contains white blood cells that can inhibit bacterial growth.  
Therefore, PRP application mitigates the currently accepted causes of alveolar  
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 osteitis  by facilitation of clot and soft tissue formation and inhibition of bacterial   
colonization.Platelet concentrates may contain small amounts of leukocytes that   
synthesize interleukins involved in the non-specific immune reaction.  
Antimicrobial activity of platelet concentrates against several bacterial species 
 involved in oral infections  has also been reported. 
 
 
In the present study dealing with 12 patients , neither the control side nor the test  
side showed any incidence of dry socket. So it can be seen that from this study that  
PRP did not have any role in the post operative incidence of dry socket. 
 
 
Furthermore, a recent retrospective study reported that PRP reduced the incidence  
of alveolar osteitis by 62%
39
. This beneficial effect is thought to be related to high  
growth factor content of PRP and its ability to initiate and stabilize blood clot in 
the extraction socket.. 
 
 
 
PRP for prevention of periodontal defects following third molar surgery
27.49
. 
 
 
The extraction of deeply included third molars may cause multiple periodontal  
defects at the distal root of the second molar. Platelet-rich plasma  can be  used in  
repairing and preventing periodontal complications at the distal root of the second 
molar adjacent to the extracted third molar. The use of PRP has shown to be a valid  
technique for promoting bone regeneration at the level of the distal surface of the 
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mandibular second molar following extraction of a mesioangularly inclined, deeply  
impacted third molar. 
 
 
 The use of PRP alone to fill the osseous defect has shown to be more valid for  
periodontal regeneration compared with the control sites, because of both the  
decrease in the periodontal defect  and the attachment gain. The mechanism by  
which  PRP can  influence periodontal regeneration is ascribed to the presence of  
PDGF and TGF-B. PDGF acts principally on osteoblastic proliferation and that, on  
the other hand, morphogenetic proteins (which are part of the TGF-B superfamily)  
act as a cellular differentiation agent favoring the expression  of  markers of  
mineralization when they are incubated with preosteoblastic cells. This suggests  
that TGF-B could favor the differentiation of osteoblasts and cementoblasts and the  
production of  fibronectin,a molecule involved in the adhesion of fibroblasts to the  
radicular  surface and in the angiogenic process. As the result of its fibrin content,  
the PRP gel permits stabilized coagulation of the blood, thereby favoring   
regeneration of  the osseous defect, particularly in the early  stages.  
 
 
Periodontal complications at the distal root surface  adjacent to the second molar  
that follow an impacted mandibular third molar in deep extraction have been  
judged to be related to the age of a patient and the angulation and severity of the  
impaction. The possibility to concentrate growth factors in a surgical wound seems  
to allow activation of  cellular events, providing a final gain in quality and time of  
healing. The use of  PRP has been shown to be a useful tool in aiding periodontal  
and bone  regeneration in vivo because of the high content of growth factors. 
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Rate of soft tissue healing
72 
 
 
Soft tissue wound healing and bone growth involve physiologic cascades in which  
cellular and hormonal factors play pivotal roles. The rationale for applying 
platelet gel is based on the delivery of platelet growth factors to tissues and on the  
fact that platelet α-granules, found inside the platelets, contain a variety of growth 
factors . Platelet gel growth factors are peptides that promote cell proliferation,  
differentiation, chemotaxis, and the migration of various cells involved in both 
wound healing
72
 .  
 
 
The numerous proteins secreted by the activated platelets influence many of the  
aspects of healing;  PDGF is chemotactic for macrophages, whereas the combined  
roles of PDGF, TGF-β, and IGF are chemotaxis and mitogenesis of stem cells 
and osteoblasts, angiogenesis for capillary in growth, bone matrix formation, and  
collagen synthesis
73
. 
 
The visual analogue scale
69
 clearly indicates the reduction of pain in the test group in  
this study. The pain on the first and third day was comparatively less in the PRP  
side than the non PRP side. There has not been a valid reason why the pain is less  
in the PRP side. But there has been many studies indicating that the application of  
PRP gel substantially reduced the pain postoperatively.   P value at the end of first post operative 
day was 0.002 for pain which was clinically significant.  
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Many authors have published various articles stating the efficiency of PRP in  
increasing the bone density, increasing soft tissue healing and decreasing pain. Some  
in vitro studies on animals showed no benefits of PRP when it was used alone
31,35,40,55
.  
Because of this uncertainity in literatures, this clinical trial was used to assess the  
efficiency of PRP , when it was used alone.  
SUMMARY AND CONCLUSION 
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Summary and Conclusion  
 
To conclude, from the study conducted we have come to a conclusion that  
platelet rich plasma has beneficial effects on the improvement of bone density,  
better soft tissue healing and  reduction of pain after mandibular third molar  
impaction surgery. But from our study we did not find any significant benefit of  
PRP on prevention of dry socket and reduction of swelling post operatively.  
 
Platelet rich plasma may have benefits in reducing complications such as alveolar  
osteitis and swelling post operatively. But there were insufficient data to support  
the use of PRP to enhance the quality of life of the patient after the impaction  
surgery since the sample size was small to statistically detect any significant  
difference.  
 
It can be concluded that  PRP is a good surgical additive without any  
side effects and which can be used to improve post operative comfort of the  
patient. The surgical adhesive thus developed provided adhesiveness and tensile  
strength  for clot stabilization. It was biologically acceptable and was a  
concentrate of growth factors. It had haemostatic as well as angiogenic properties. 
Moreover the product showed the potential for wound healing and osteoconduction. 
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Annexure I 
Informed consent 
 
Why do this study? – we are interested in evaluating the efficiency of platelet rich plasma in 
healing after third molar impaction surgery. We need to collect data from patients  whose 
extraction sockets have been treated with this platelet concentrate to help us compare the results 
and conclude whether it is better in clinical trial 
 
What will participation involve? -During this study, in the selected patients with bilaterally 
impacted mandibular third molars, we treat one side as the test where the platelet rich plasma is 
placed and the other side is left as control. Postoperatively we determine the bone density, soft 
tissue healing, pain , swelling and alveolar osteitis reviewing the patient at specific time 
intervals. 
 
How long will participation take ?  -the entire surgical procedure will last one to one and a half 
hours. There is need for additional visits to the hospital with regard to the research study. 
 
As an informed participant of this study, I understand that: 
My participation is voluntary and I may cease to take part in this experiment at any time, without 
any penalty.  
I am aware of what my participation involves 
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There are no risks involved in the participation of this study. 
All my questions about this study and procedures are satisfactorily answered. 
I have read and understood the above , and give my consent to participate  
 
Participants signature __________________ Date ______________ 
 
I have explained the above and answered all questions asked by the participant 
 
Researchers signature_________________ Date _______________ 
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Annexure II 
CASE HISTORY PROFORMA 
Date:  
Name :  
Age/Sex :  
Address :  
 
 
 
Occupation :  
Chief Complaint :  
History of Presenting Illness :  
Past Medical History :  
Drug Allergy :  
Past Dental History :  
Family History :  
Personal History :  
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Vital signs  Systemic Examination:  
 BP 
 Pulse  
 Respiratory rate 
 Temperature  
 Weight  
General examination 
 Jaundice 
 Anaemia 
 Clubbing 
 Cyanosis 
 Lymphadenopathy 
 Oedema  
  CNS 
 CVS 
 RS 
 GIT  
Extra Oral Examination  
 Facial asymmetry 
 Mouth opening 
 Deviation on mouth opening 
 Swelling, tenderness 
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Intra-Oral Examination  
 Soft tissue examination 
 Hard tissue examination 
 Occlusion  
 
Provisional Diagnosis 
Investigations  
Final Diagnosis  
Treatment Plan   
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ANNEXURE III 
   
PATIENT DATA FORM 
 
NAME : 
 
AGE :  
 
ADDRESS : 
 
DAY OF REVIEW: 
 
 
ASSESSMENTS: 
 
1. PAIN 69 
2. SWELLING70 
3. SOFT TISSUE HEALING71 
4. ALVEOLAR OSTEITIS 
5. RADIOGRAPHY  ( OPG ) 
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Annexure IV 
 
Numeric visual analog scale
69
 
 
 
 
 
